PatentsGlobal
Aptar Pharma Files New Patents and Reveals Preclinical Advances in Intranasal and Pulmonary GLP-1 Delivery
Aptar Pharma has announced the publication of three international patent applications centered on inhaled and nasal delivery of GLP-1-based biologics. Supported by preclinical pharmacokinetic data demonstrating significant improvements in systemic drug exposure, these filings reflect the company’s strategic expansion…
Thursday, May 28, 2026